TOPページ
|
英語
日本語
|
CONNECT WITH US:
ホーム
JCNについて
サービス
お問い合わせ
会員企業ログイン
ホーム
プレスリリース
2023年07月31日 21時00分
Source:
China Medical System Holdings Ltd.
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management
SHENZHEN, CHINA, 2023年07月31日 - (JCN Newswire) - Recently, MSCI (Morgan Stanley Capital International), the world's largest index company, announced the latest Environmental, Social, and Governance (ESG) evaluation report for China Medical System Holdings limited ("CMS" or the "Group"), who achieved an "AA" rating and surpassed 75% of global peers with leading ESG management practices.
MSCI is one of the most widely used, influential, and referenced rating companies in the global market. Based on a scientifically rigorous evaluation system, it evaluates companies' risk control performance and sustainable development potential comprehensively from various aspects such as environment, human capital, health accessibility, product safety and quality, and corporate governance. MSCI-ESG rating results have been regarded by global investors as an important non-financial basis for investment decision-making. Being back to the "AA" rating, reflects the full recognition of the Group's ESG management practices by the international authoritative rating company.
The Group deeply integrates the concept of sustainable development into its operations with a development perspective, continuously improves its internal governance under the guidance of its ESG strategy, and actively assumes its responsibilities as a corporate citizen. Based on years of continuous investment in sustainable development, CMS's ESG management has been widely recognized: over the past three years, the Group's MSCI-ESG rating has maintained an "A" or "AA; its S&P Global ESG score surpassed 92% of the global peers with a score of 53, and successfully stood out from approximately 1,600 Chinese companies to be included in the first "Sustainability Yearbook (China)" of S&P Global.
In the future, CMS will always keep in mind its mission of being a responsible citizen, and work together with its stakeholders to promote healthy, harmonious, and sustainable development of the industry, society, and environment.
About CMS:
CMS (0867.HK) is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet healthcare needs.
CMS focuses on developing first- or best-in-class innovative products and has made the layout of 30 differentiated pipeline products with strong market potential. CMS deeply engages in specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to strengthen the competitiveness of its cardio-cerebrovascular/gastroenterology business, and independently operated dermatology and medical aesthetic business, and ophthalmology business, whilst enhancing the scale and efficiency. CMS also entered into the Southeast Asian market to create new opportunities to further enhance the sustainable development of the Group.
Media Contact
Brand: China Medical System Holdings Ltd.
Contact: CMS Investor Relations
Email:
ir@cms.net.cn
Website:
https://web.cms.net.cn/en/home/
Source: China Medical System Holdings Ltd.
Source: China Medical System Holdings Ltd.
セクター: ヘルスケア, メドテック
Copyright ©2023 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
関連プレスリリース
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
2023年08月24日 21時00分
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China
2023年06月12日 21時00分
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China
2023年05月30日 23時00分
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy
2022年08月26日 19時00分
もっと見る >>
新着プレスリリース
eDrivingより、自動車関連企業向けのサステナビリティ・レポーティング・ソリューション(持続可能性についての報告に関するソリューション機能)である新しいEcoReportを発表
2023年11月30日 22時00分
トヨタ、デンソーとの資本関係を見直し
2023年11月29日 16時00分
トヨタ、2023年10月 販売・生産・輸出実績を発表
2023年11月29日 13時30分
三菱造船、液化CO2船舶輸送の実証試験船の命名引渡式を下関で実施
2023年11月28日 17時00分
CNN東京特派員にモンゴメリー花子が着任
2023年11月24日 11時00分
Fernando Mezzomo, CEO of Antidote, Announces their Platform Launch with Closed Community X on It
2023年11月23日 22時37分
Novationwire, the Leading Earned Media Newswire, Officially Enters the Vietnam Market
2023年11月23日 14時50分
GPT-PRHelper to Disrupt Southeast Asia's PR Distribution Landscape, Says AsiaPresswire at Product Debut
2023年11月21日 16時05分
Revolutionizing Press Release Creation and Global Distribution, AsiaPresswire Rolls out AI Solution GPT-PRHelper
2023年11月20日 10時00分
CNN、「Next Big Trip」で日本の秘境の隠れた魅力を発見
2023年11月17日 17時00分
Novationwire Launches Cutting-Edge AI Platform Empowering Singapore SMBs to Boost Brand Influence
2023年11月17日 13時45分
Chiratae Ventures India、日本からアジア地域アドバイザリーボードとして渋澤健氏を迎え入れ、アジア事業を強化
2023年11月17日 09時37分
川崎市と富士通、環境に配慮した行動変容を促進し脱炭素に向けた取組を加速
2023年11月16日 11時00分
CNN、「Food for Thought」で東京の多様な食文化を探求
2023年11月16日 10時50分
Novationwire's AI-Driven ABL Platform Streamlines Press Release Distribution for Clients
2023年11月15日 16時00分
Bluelight.inc is Getting Released on the Mainnet
2023年11月14日 17時00分
Novationwire Debuts AI-EDITOR, the AI-Powered Editing Tool to Boost Press Release Performance
2023年11月14日 09時00分
BTSのVが’KMチャート’で2冠王トロフィー受賞、KMチャート決算アワード’USA’開催予定
2023年11月13日 10時00分
Novationwire Launches Arabic PR Distribution Tailored for Middle East Markets
2023年11月10日 17時00分
ソフトバンク、富士通のディスアグリゲーション型光伝送装置を採用したAll optical networkを、全国伝送網のコア領域へ展開完了
2023年11月10日 14時00分
もっと見る >>